| __timestamp | BioMarin Pharmaceutical Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 621276000 | 52602000 |
| Thursday, January 1, 2015 | 737887000 | 105812000 |
| Friday, January 1, 2016 | 907234000 | 113485000 |
| Sunday, January 1, 2017 | 1071860000 | 285461000 |
| Monday, January 1, 2018 | 1175948000 | 141726000 |
| Tuesday, January 1, 2019 | 1344582000 | 150446000 |
| Wednesday, January 1, 2020 | 1336183000 | 224227000 |
| Friday, January 1, 2021 | 1375760000 | 361897000 |
| Saturday, January 1, 2022 | 1612370000 | 520812000 |
| Sunday, January 1, 2023 | 1842161000 | 636892000 |
| Monday, January 1, 2024 | 2273680000 | 855907000 |
Unleashing insights
In the competitive landscape of biotechnology, BioMarin Pharmaceutical Inc. and Halozyme Therapeutics, Inc. have been pivotal players. Over the past decade, BioMarin has consistently outperformed Halozyme in terms of gross profit. From 2014 to 2023, BioMarin's gross profit surged by nearly 200%, reaching its peak in 2023. In contrast, Halozyme, while showing growth, achieved a more modest increase of approximately 110% over the same period.
BioMarin's strategic focus on rare genetic diseases has paid off, with its gross profit in 2023 being almost three times that of Halozyme. Meanwhile, Halozyme's innovative drug delivery platforms have driven its growth, albeit at a slower pace. This data underscores the importance of strategic focus and innovation in the biotech industry, offering valuable insights for investors and industry enthusiasts alike.
AbbVie Inc. and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Novartis AG vs BioMarin Pharmaceutical Inc.
Gross Profit Comparison: United Therapeutics Corporation and BioMarin Pharmaceutical Inc. Trends
Genmab A/S and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Incyte Corporation vs Halozyme Therapeutics, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Viatris Inc. vs Halozyme Therapeutics, Inc.
Who Generates Higher Gross Profit? BioMarin Pharmaceutical Inc. or Perrigo Company plc
Key Insights on Gross Profit: BioMarin Pharmaceutical Inc. vs HUTCHMED (China) Limited
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Who Generates Higher Gross Profit? Halozyme Therapeutics, Inc. or Amneal Pharmaceuticals, Inc.
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs HUTCHMED (China) Limited
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.